| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 19 |
| 1 | FLUOROURACIL CREAM, 0.5% | 19 |
| 2 | FUROSEMIDE | 19 |
| 3 | FRUQUINTINIB | 17 |
| 4 | OXALIPLATIN | 17 |
| 5 | CLOPIDOGREL | 16 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 16 |
| 7 | CLOPIDOGREL BISULFATE | 13 |
| 8 | APIXABAN | 12 |
| 9 | ATENOLOL | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FRUQUINTINIB | 17 | 0.0043 |
| 1 | TOREMIFENE CITRATE | 1 | 0.0023 |
| 2 | DINOPROSTONE | 1 | 0.0012 |
| 3 | NALOXONE HCL | 1 | 0.0012 |
| 4 | MIGLITOL | 1 | 0.0010 |
| 5 | REGORAFENIB | 9 | 0.0008 |
| 6 | DASATINIB | 6 | 0.0006 |
| 7 | DAPRODUSTAT | 1 | 0.0005 |
| 8 | ATROPINE SULFATE INJECTION | 1 | 0.0004 |
| 9 | ATROPINE SULFATE MONOHYDRATE | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 29 |
| 1 | Proton Pump Inhibitor [EPC] | 26 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 24 |
| 3 | Platinum-based Drug [EPC] | 23 |
| 4 | Loop Diuretic [EPC] | 21 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 21 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 19 |
| 7 | Factor Xa Inhibitor [EPC] | 18 |
| 8 | beta-Adrenergic Blocker [EPC] | 17 |
| 9 | Benzodiazepine [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 3 | Oxytocic [EPC] | 1 | 0.0003 |
| 4 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 5 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 6 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 12 | 0.0002 |
| 7 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 8 | 0.0002 |
| 9 | Parenteral Iron Replacement [EPC] | 2 | 0.0001 |